FXH ETF Analysis: Health Care AlphaDEX Fund | NYSE
Health | NYSE, USA | Market Cap: 1.012m USD | 12M Return: 24.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.12M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality
The First Trust Health Care AlphaDEX® Fund (FXH) is an exchange-traded fund that invests at least 90% of its net assets in securities comprising its underlying index, a modified equal-dollar weighted benchmark that draws stocks from the Russell 1000® Index within the health care sector. The index applies the proprietary AlphaDEX® selection methodology, which uses quantitative factor screens to rank and select companies that may outperform traditional capitalization-weighted benchmarks. The health care sector tracked by the fund spans subsectors such as pharmaceuticals, biotechnology, medical devices, and health care services providers. As a modified equal-dollar weighted index, holdings are periodically rebalanced so that each constituent receives approximately equal dollar allocations rather than weights based on market capitalization.
- Healthcare sector rotation drives ETF inflows and outflows
- AlphaDEX methodology outperformance versus cap-weighted health benchmarks
- Drug pricing reform legislation pressures constituent pharma margins
As of July 28, 2026, the stock is trading at USD 125.11 with a total of 36,780 shares traded. Over the past week, the price has changed by +2.43%, over one month by +1.81%, over three months by +10.23% and over the past year by +24.62%.
Current recommended Stop Loss: 122.80 (which is 1.8% or 1.3 ATR below the current price).
Health Care AlphaDEX Fund has no consensus analysts rating.